---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-015711"
form_type: "8-K"
ticker: null
cik: "0001792581"
company_name: "Kiromic Biopharma, Inc."
filed_at: "2023-09-13T23:59:59+00:00"
generated_at: "2026-06-10T19:16:00.207879+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Kiromic BioPharma receives Nasdaq delisting notice; stock moves to OTC Pink

## Summary
- Received formal notice on Sept 12, 2023 for failure to comply with Nasdaq Listing Rule 5550(b)(1).
- Trading on Nasdaq Capital Market suspended effective Sept 14, 2023.
- Common stock will trade on OTC Pink Sheets under ticker KRBP starting Sept 14.
- Company will pursue uplisting to OTCQB but no assurance of market development.
- Delisting not expected to impact day-to-day operations, per company statement.

## SEC filing metadata
- accession: 0001558370-23-015711
- form_type: 8-K
- cik: 0001792581
- company_name: Kiromic Biopharma, Inc.
- filed_at: 2023-09-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792581/000155837023015711/0001558370-23-015711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792581/000155837023015711/krbp-20230912x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-015711
- JSON: https://secwatch.observer/filing/0001558370-23-015711.json
- Plain text: https://secwatch.observer/filing/0001558370-23-015711.txt

## Key facts
- Listing & Compliance Notices
  Kiromic Biopharma, Inc. received a nasdaq delisting notice notice regarding other.
  - Exchange: nasdaq
  - Notice: delisting notice
  source text: September 12, 2023, Kiromic Biopharma, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that it would delist the Company’s shares of common stock from the Nasdaq Capital Market upon the opening of trading on September 14, 2023. The Company’s common stock will be traded on the OTC Pink Sheets while it pursues an uplisting to the OTCQB exchange and seeks to establish relationships with market makers to provide additional trading opportunities in the Company’s stock. However, there can be no assurance that a market for the Company’s shares w
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792581/000155837023015711/0001558370-23-015711-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.